Chronic Disease Management Market Trends

  • Report ID: 4242
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Chronic Disease Management Market Trends

Growth Drivers

  • Increasing Geriatric Population with Decreased Immunity– Despite weak immune systems aging brings several other health issues that require intensive care and health monitoring of old people. So, an increase in the geriatric population is fueling the demand for chronic disease management. According to the data provided by the World Health Organization (WHO), the population of people aged 60 and up has increased from 1 billion in 2020 to 1.4 billion around the globe.
  • Rise in Musculoskeletal Diseases - A collection of illnesses known together as musculoskeletal disorders affect the bones, tendons, muscles, cartilage, and other components of the musculoskeletal system. For instance, back discomfort, osteoarthritis, rheumatoid arthritis, and osteoporosis are among these disorders. Furthermore, if osteoarthritis treatment is not provided effectively, can lead to major health issues. In addition, musculoskeletal ailments are the main cause of disability worldwide. For instance, worldwide, 1.71 billion people have been suffering from musculoskeletal conditions.

Challenges

  • High-Cost Associated with Chronic Diseases Treatment- Chronic diseases are long-term illnesses that need treatment for a lifetime in many cases, such as diabetes. The medications and therapy procedures for chronic diseases are very expensive such as chemotherapy in the case of cancer. HIV and AIDS also include in this category, hampering the growth of the market.
  • High Initial Investments
  • Lack of Trained Workforce with Cross-Functional Skills

Chronic Disease Management Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

14.6%

Base Year Market Size (2024)

USD 7.99 billion

Forecast Year Market Size (2037)

USD 46.56 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4242
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of chronic disease management is assessed at USD 8.93 billion.

The chronic disease management market size was over USD 7.99 billion in 2024 and is expected to reach USD 46.56 billion by the end of 2037, growing at around 14.6% CAGR during the forecast period i.e., between 2025-2037. Increasing use of tobacco across the globe and the worldwide upsurge in chronic obstructive pulmonary disease (COPD) will boost the market growth.

North America industry is predicted to account for the largest share of 47% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market include WellSky Corporation, Cedar Gate Technologies, Pegasystems Inc., Koninklijke Philips N.V, Altruista Health, Cognizant TriZetto Software Group Inc, Infosys Limited, Hinduja Global Solutions Ltd., Epic Systems Corporation, NXGN Management.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample